| Sep 22 |
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
|
| Sep 22 |
This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy?
|
| Sep 20 |
Keytruda beaten by Summit’s bispecific in NSCLC
|
| Sep 19 |
Summit Therapeutics files to sell 10.35M shares of common stock for holders
|
| Sep 19 |
Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial
|
| Sep 19 |
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
|
| Sep 19 |
Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?
|
| Sep 18 |
This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.
|
| Sep 17 |
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
|
| Sep 17 |
Here's Why Everyone's Talking About Summit Therapeutics
|
